← Back to Search
INV-102 0.1% BID for Dry Eye Syndrome
This trial tests INV-102 eyedrops for safety & effectiveness in treating moderate dry eye disease over 2 weeks. Part 1 assesses safety & Part 2 assesses efficacy.
- Dry Eye Syndrome
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many individuals are currently included in this clinical trial's patient cohort?
"Affirmative. According to clinicaltrials.gov, this medical trail is open for participants as of August 30th 2022 and was recently updated on October 14th 2022. 72 patients are being sought out by one healthcare facility for the study's duration."
Is there an opportunity to enroll in this experiment at the present time?
"Data from clinicaltrials.gov indicates that this research study is actively seeking participants, with the trial having been posted on August 30th 2022 and updated as of October 14th 2022."